Anti-phospho-FAK (Tyr397)

Code: ABT135 D2-231

Analysis Note

Controluntransfected and Src-transfected RAT2 cell lysates

Application

Peptide Inhibition Assay Analysis: A 1:1,000 dilution from a...


 Read more

Your Price
€454.00 EACH
€558.42 inc. VAT

Analysis Note

Controluntransfected and Src-transfected RAT2 cell lysates

Application

Peptide Inhibition Assay Analysis: A 1:1,000 dilution from a representative lot peptide blocked on RAT2 cells transfected with Src.

Detect phospho-FAK (Tyr397) using this Anti-phospho-FAK (Tyr397) Antibody validated for use in WB, Cell Function Assay.

Research CategoryCell Structure

Research Sub CategoryAdhesion (CAMs)

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Focal adhesion kinase (FAK) is a non receptor protein tyrosine kinase discovered as a substrate for Src and a key element in integrin signaling. FAK plays a central role in cell spreading, differentiation, migration, cell death and acceleration of the G1 to S phase transition of the cell cycle. FAK regulation includes phosphorylation at multiple tyrosine and serine residues. Phosphorylation of tyrosine is generally associated with positive regulation and growth promotion; however, dephosphorylation at these sites occurs as cells enter mitosis (M-Phase). In contrast, serine phosphorylation either remains high or is increased as cells enter mitosis and may play a role in focal adhesion disassembly. FAK and its phosphorylation states have been implicated in cancer metastasis, tumor cell survival, and adhesion-independent growth. Recent evidence indicates that elevation of FAK activity in human carcinoma cells is associated with increased invasive potential. A central role in tumor formation and progression suggests that FAK is an attractive target for therapeutic intervention. Activation of FAK by integrin clustering leads to autophosphorylation at Tyr397.

Immunogen

Epitope: Phosphorylated Tyr397

KLH-conjugated linear peptide corresponding to human FAK phosphorylated at Tyr397.

Linkage

Replaces: 04-974

Physical form

Affinity purified

Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Quality

Evaluated by Western Blot in untransfected and Src-transfected RAT2 cell lysates.

Western Blot Analysis: A 1:1,000 dilution of this antibody detected phospho-FAK (Tyr397) in 10 µg of untransfected and Src-transfected RAT2 cell lysates.

Specificity

This antibody recognizes FAK phosphorylated at Tyr397.

Storage and Stability

Stable for 1 year at 2-8°C from date of receipt.

Target description

~125 kDa observed.
An uncharacterized band appears at ~190 kDa in some lysates.

antibody formaffinity isolated antibody
antibody product typeprimary antibodies
biological sourcerabbit
clonepolyclonal
Gene Informationhuman ... PTK2(5747)
NCBI accession no.NP_722560
purified byaffinity chromatography
Quality Level100
shipped inwet ice
species reactivity (predicted by homology)chicken (based on 100% sequence homology), Xenopus (based on 100% sequence homology), mouse (based on 100% sequence homology), human (based on 100% sequence homology)
species reactivityrat
technique(s)cell based assay: suitable, western blot: suitable
UniProt accession no.Q05397
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.